Introduction: Non-Hodgkin lymphoma (NHL) is a heterogeneous group of malignancies with
more than 30 different subtypes. Follicular lymphoma (FL) is the most common form of …

Advances in the understanding of FL biology, molecular characteristics and clinical risk
factors are further highlighting the heterogeneity of this disease. Historically used prognostic …

Follicular lymphoma (FL) has a long natural history and typically indolent behavior. In the
present era, there are a plethora of prognostic factors combining clinical, biological, and …

Follicular lymphoma (FL) is one of the most common indolent non-Hodgkin lymphoma (NHL)
subtype in Western countries. Although understanding of the epidemiology of NHL subtypes …

Follicular lymphoma is a far more heterogeneous entity than originally appreciated. Clinical
and biological variants are increasingly more granularly defined, expanding the spectrum of …

Abstract Purpose of Review Follicular lymphoma is a diverse disease, with a diverse
variable biology, clinical presentation, and prognosis. The identification of factors that can …

Follicular lymphoma (FL) is a common disease with clinically indolent behavior, and a long
natural history for the majority of patients. Despite excellent therapeutic strategies currently …

Opinion statement Even in the modern era, follicular lymphoma (FL) remains largely an
incurable but treatable disease with both standard and novel treatment modalities. Despite …

Recent insights into follicular lymphoma identify constitutional and environmental
predisposition further unravelling the concept of a lymphoma-initiating cell and the acquired …

Follicular lymphoma (FL) is the most common subtype of indolent lymphoma. Specific “facts”
about FL that were generated by past research and have been passed down as dogma to a …